Targeted dosing to treat pediatric inflammatory bowel disease is challenging because dosing guidelines are based on data gathered from adult subjects of clinical trials. Patients’ families and health care organizations also incur high costs and must try to balance potential benefits against risks of ongoing monitoring.
AMA J Ethics. 2018;20(9):E841-848. doi:
10.1001/amajethics.2018.841.
Katrina A. Bramstedt, PhD, MA and Jean-Baptiste Hoang
Some technological and policy strategies for increasing organ supplies are ethically and legally proven to work. Consider best next steps for global education efforts to raise organ donation awareness.
AMA J Ethics. 2016;18(2):143-152. doi:
10.1001/journalofethics.2017.18.2.pfor2-1602.